Adiuva Capital has acquired Ascopharm GmbH and Revomed GmbH from the company founder Karl-Heinz Oppermann in a management buyout transaction.
Founded in 1977, Ascopharm provides high quality nutritional supplements, OTC drugs, minerals, vitamins, and cosmetics. From its headquarters in Wernigerode, Germany, the company supplies over 200,000 regular customers. The products are sold under the Ascopharm and Sovita brands to consumers. B2B customers are served through the Revomed brand.
Adiuva Capital is a long-term oriented, entrepreneurial investment company. With headquarters in Hamburg, Adiuva is owner-managed and provides equity for medium-sized European enterprises, with a particular focus on the German-speaking region.
Adiuva Capital acquired Ascopharm as part of a succession arrangement from the company founder Karl-Heinz Oppermann and will support Ascopharm in expanding their product portfolio, developing the B2B part of the business, and strengthening the online activities. Hannelore Hütcher becomes Managing Partner of Ascopharm.
Oaklins' team in Germany acted as the exclusive financial advisors to the seller and structured the entire M&A process.
Dr. Martin Kanjuh
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.